Product List | ||
API&Intermedia | ||
Product Name | CAS Non. | Applicationem |
2-Methylindoline | 6872-06-6 | Indapamide medium est |
1-Amino-2-methylindolinehydrochloride | 102789-79-7 | |
Acidum 4-chloro-3-sulphamoylbenzoicum | 1205-30-7 | |
4-Chloro-3-sulfamoylbenzoylchloride | 70049-77-3 | |
1-(3-Methoxyphenyl)piperazine | 16015-71-7 | Medium Letermovir |
1-(3-Methoxyphenyl)piperazinum dihydrochloride | 6968-76-9 | |
2-broMo-6-fluorobenzenaMine | 65896-11-9 | |
(2-Methoxy-5-(trifluoromethyl)aniline) | 349-65-5 | |
Acidum 2-propenoicum, 3-(2-amino-3-fluorophenyl)-, yl ester, (2E)- | 690664-20-1 | |
4-Quinazolineaceticum acidum 8-fluoro-1,2,3,4-tetrahydro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-2-oxo-, yl ester | 917389-21-0 | |
acidum 2-propenoicum, 3-[3-fluoro-2-[(phenoxycarbonyl)amino]phenyl]-, methyl ester, (2E)- | 1791412-01-5 | |
1-Methylindole | 603-76-9 | AZD9291(Osimertinib) medium |
N,N,N'-Trimethylethylenediamine | 142-256 | |
3-(2-chloropyriMidin-4-yl) -1-Methylindole | 1032452-86-0 | |
4-fluoro-2-Methoxy-5-nitroaniline | 1075705-01-9 | |
1-(1-ethoxyethyl) -4-(4,4,5,5-tetramethyl-1,3,2 -dioxaborolan-2-yl)-1H-pyrazole | 1029716-44-6 | Ruxolitinib's medium |
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 | |
3-cyclopentylacrylonitrile | 591769-05-0 | |
Cyclopentanecarbaldehyde | 872-53-7 | |
2-amino-3,5-dibromopyrazine | 24241-18-7 | Upadacitinib's medium |
1,1-Cyclopentanediacetic Acid | 16713-66-9 | |
3,3-Tetramethyleneglutarimide | 1075-89-4 | Buspirone's medium |
1-(2-Pyrimidinyl) | 20980-22-7 | |
5-methyl-1,3,4-oxadiazoli-2-acidi potassii salis carboxylici | 888504-28-7 | Raltegravir's medium |
yl 2-[1-[[(benzyloxy)carbonyl]amino]-1-methylethyl]-5,6-dihydroxypyrimidine-4-carboxylato | 519032-08-7 | |
5-Methyl-2(1H)-Pyridinone | 1003-68-5 | Pirfenidone's medium |
((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol -4-yl) methyl isobutyrate | 2346620-55-9 | Molnupiravir in medium |
1-bromo-3-methyl-2-buten | 870-63-3 | Sofalcone medium |
Natrium sal Tianeptine | 30123-17-2 | Anti-cavum medium |
7-Methoxy-1-tetralone | 6836-19-7 | Agomelatine medium |
4-(4-broMo-3-(hydroxyMethyl)phenoxy)benzonitrile | 906673-45-8 | Crisaborole est medium |
Methyl 4,6-dichloropyridazinum-3-carboxylatum | 372118-01-9 | Deucravacitinib's medium |
4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 | tofacitinib, Ruxolitinib's medium |
(R)-(+)-2-Acidi tetrahydrofuroici | 87392-05-0 | Faroenem's medium |
Methyl 4-chloro-4-oxobutanoate | 1490-25-1 | medium |
2,5,6-tetrachloropyridine | 54718-39-7 | |
p-Tolylhydrazinehydrochloride | 637-60-5 | |
Phenylhydrazine hydrochloride | 59-88-1 | |
Cocarboxylase | 154-87-0 | |
1-Bromo-4-iodobenzene | 589-87-7 | |
4-Iodonitrobenzene | 636-98-6 | |
2-Acetyl-4-methylpyridine | 59576-26-0 | Alpelisib Intermedia |
1,1,1-Trifluoro-2- (4-methylpyridin-2-yl) propanol | 1396893-43-8 | Alpelisib Intermedia |
4-Methyl-2- (1,1,1-trifluoro-2-dimethyl-2-ethyl) pyridine | 1378865-93-0 | Alpelisib Intermedia |
4-Chloropyrrolidine | 3680-69-1 | Intermedia Tofacitinib |
1,4-Chloro-7-p-toluenesulfonyl-7H pyrrolo [2,3-d] pyrimidine. | 47963-63-1 | Intermedia Tofacitinib |
(3R, 4R) -1-benzyl-3- (methylamino) -4-methylpiperidine dihydrochloride;Cis 1-benzyl-4-methyl-3-methylamino piperidine dihydrochloride | 1062580-52-2 | Intermedia Tofacitinib |
(2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinicium acidum succinicum et (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidinem amineum | 477600-71-8 | Intermedia Tofacitinib |
Fumarate vorolazan | 1260141-27-2 | Vonolazan medium |
2 - (2 - (2-fluorobenzene) - 2-oxyethyl) propiononitrile | 312307-38-3 | |
2-Chloro-5 - (2-fluorophenyl) - 1H-pyrrole-3-acetonitrile. | 1240948-72-4 | |
5 - (2-fluorophenyl) - 1H-pyrrole-3-acetonitrile | 1240948-77-9 | |
5 - (2-fluorophenyl) pyrrole-3-formaldehyde | 881674-56-2 | |
5 - (2-fluorophenyl) - 1 - [(pyridin-3-yl) sulfonyl] - 1H-pyrrol-3-formaldehyde | 881677-11-8 | |
5 - (2-fluorophenyl) - N-methyl-1 - (3-pyridylsulfonyl) - 1H-pyrrol-3-methylamine. | 881681-00-1 | |
Pyridine-3-sulfonylo chloride | 16133-25-8 | |
thiolactone | 28092-52-6 | |
Porphyrion E6 | 19660-77-6 | |
(S) - (+) -2,2-dimethyl-1,3-dioxocyclopent-4-methylbenzenesulfonate | 23735-43-5 | |
Biluvadine pentapeptide | 1450625-21-4 | Biluvadine pentapeptide media |
3-Chlorophenylacetone | 936-59-4 | Medium dapoxetine |
1- [3- (Acetoxy) phenyl] -2-bromoethanone | 38396-89-3 | |
10- (2-Chloropyrimidin-4-yl) -6,7,8,9-tetrahydropyridino [1,2-a] indole | 2035090-53-8 | |
6-Bromo-8-chloro-3,4-dihydronaphthalene-2 (1H) - one | 1337847-33-2 | |
Ethyl chlorofluoroacetate | 401-56-9 | |
2-Chlorobenzimidazole | 4857--6--1 | |
6-Bromo-8-fluoro-3,4-dihydronaphthalene-2 (1H) - one | 1337857-08-5 | |
N-acetyl-3- (3,5-difluorophenyl) - DL alanine | 266360-52-5 | |
4. (methoxycarbonyl) - alpha-2-propargyl-phenylacetatum methyl ester | 146464-90-6 | |
2-Mercaptopyridine | 2637-34-5 | |
3-Mercaptopyridine | 109-00-2 | |
3,5-Dimethyl-2-pyrrolaldehyde | 2199-58-8 | |
3,5-Dimethyl-4-nitropyrrole-2-formaldehyde | 40236-20-2 | |
(3S) -3- [4- [(2-chloro-5-iodophenyl) methyl] phenoxy] | 915095-94-2 | |
4-Cyano-2-methoxybenzaldehyde | 21962-45-8 | |
4-Amino-5-methyl-2-hydroxypyridine | 95306-64-2 | |
17-amino-10-oxy-3,6,12,15-tetraoxa-9-azaheptadecanoicum acidum | 1143516-05-5 | |
L-proline tert butyl ester | 281-246-6 | |
S-3-aminoquininum cycloamine hydrochloridum | 119904-90-4 | Medium Palonosetron |
(S) - 1,2,3,4-tetrahydro-acidi 1-naphthoici | 85977-52-2 | |
5,6,7,8-tetrahydro-1-naphthoicum acidum | 4242-18-6 | |
Sodium bisulfite solution | 7631-90-5 | Reductans, conservans, decolorat, sanitizet. |
Cyclopentanone | 120-92-3 | photographicae materiae, medicinae et unguenti industriae |
2-Adamantanone | 700-58-3 | materiae photographicae, media pharmaceutica. |
2-Methylindole | 95-20-5 | medium |
2,3,3-Trimethylindolenine | 1640-39-7 | |
2,3,3,5-Tetramethylindolenine | 25981-82-2 | |
2,5-Dimethylindole | 1196-79-8 | |
1,2-Dimethylindole | 875-79-6 | |
Indole-3-carbinol | 700-06-1 | |
Indole-3-carboxaldehyde | 487-89-8 | |
Cyclopentylpropionyl chloride | 104-97-2 | materiam LCD. |
4-Methoxymethyl-2,3,5,6-tetrafluorobenzylalcohol | 83282-91-1 | Pesticidium medium est |
7ACF | 80370-59-8 | |
7-ACQ | 103122-02-7 | |
Bromoacetonitrile | 590-17-0 | paxlovid medium |
2-Fluoro-3- (trifluoromethyl) acidum benzoicum | 115029-22-6 | |
4,4-Dimethoxy-2-butanone | 5436-21-5 | medium pro pharma/agri-chem |
2-Chloropyridine-3-sulphonylum chloridum | 6684-06-6 | |
P-hydroxythiobenzamide | 25984-63-8 | Febuxostat intermedia |
Acidum cyanoisonicotinicum 2-myl ester | 94413-64-6 | Topiroxostat Medium |
3,4-Dimethoxy-2-methylpyridine-N-oxide | 72830-07-0 | Pantoprazole medium |
2-Amino-6-bromopyridine | 19798-81-3 | Filgotinib medium |
Methyl 2-methoxy-4-aminobenzoate | 27492-84-8 | Lenvatinib medium |
Cyclopropane acetonitrile | 6542-60-5 | |
Acidum aceticum cyclopropaneum | 5239-82-7 | |
Butyl phosphas anhydride | 163755-62-2 | Substitutio propyl phosphas anhydride |
A-Amino-2,4-difluorophenylaceticum acidum | 240409-02-3 | Fexuprazan medium |
2-acidi cyanoisonicotinicum | 161233-97-2 | Topiroxostat Medium |
2-Cyano-3-fluoropyridine✱ | 97509-75-6 | |
Trimethylcyanosilane | 7677-24-9 | altilium electrolytici |
2-Cyano-5-bromopyridine | 97483-77-7 | tedizolid medium |
3-Bromopyridine | 626-55-1 | |
3-Bromo-4-Nitropyridine | 89364-04-5 | |
2-Amino-5-bromopyridine | 1072-97-5 | Palbociclib medium |
2.3.5-Trimethyl-4-nitropyri-N-oxide | 86604-79-7 | Omeprazole medium |
3,5-bis (trifluoromethyl) thiobenzamide | 317319-15-6 | |
3,5-Bistrifluoromethylbenzonitrile | 27126-93-8 | |
3- (3,5-bis (trifluoromethyl) phenyl) -1H-1,2,4-triazolum | 1333154-10-1 | Selinexor medium |
(Z) -3- (3-(3,5-bis (trifluoromethyl) phenyl) -1H-1,2,4-triazol-1-yl) isopropyl acrylatum | 1333152-22-9 | |
KPT-330 medium | 1388842-44-1 | |
Saliniso | 1393477-72-9 | |
4-Amino-5-methyl-2-hydroxypyridine | 95306-64-2 | Finerenone Intermedia |
Ethyl 2-cyanoacetate | 65193-87-5 | |
4-Chloropyrrolidine | 3680-69-1 | Abrocitinib |
3-Oxocyclobutanyl acidum carboxylicum | 23761-23-1 | Atopic DERMATITIS |
2-Nitro-5-bromopyridine | 39856-50-3 | Palbociclib |
2-Nitro-5-Chloropyridine | 52092-47-4 | |
6-Nitro-1H-indazole | 7597-18-4 | 319460-85-0 Axitinib Intermedia |
6-Amino-1H-indazole | 6967-12-0 | |
6-Iodo-1H-indazole | 261953-36-0 | |
3-Iodo-6-nitro-1H-indazole | 7031-70-7 | |
2,2'-dithiobis[N-methylbenzamide] | 2527-58-4 | |
2-Mercapto-N-methylbenzamide | 20054-45-9 | |
3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)1H-indazole | 886230-74-6 | |
(E) -6-nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)1H-indazole | 886230-75-7 | |
(E) -3-[2-(pyridin-2-yl) ethenyl] -1-(tetrahydro-2H-pyran-2-yl) -1H-indazol-6-amine | 886230-76-8 | |
(E) -6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)1H-indazole | 886230-77-9 | |
2-[(3-Iodo-1H-indazol-6-yl)thio]-N-methylbenzamide | 885126-34-1 | |
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl) ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide | 885126-35-2 | |
2-Acetyl-4-chlorothiophene | 34730-20-6 | 677007-74-8 Avatrombopagmaleate intermedium |
4-(4-Chloro-2-thienyl)-2-thiazolamine | 570407-10-2 | |
1-Cyclohexylpiperazine | 17766-28-8 | |
5,6-acidi dichloronicotinicum | 41667-95-2 | |
5-Chloro-6-[4-(ethoxycarbonyl)piperidino]-nicotinicacid | 931395-73-2 | |
4-(4-chlorothiophen-2-yl) -5-(4-cyclohexylpiperazin-1-yl) thiazol-2-amine | 570407-42-0 | |
5,6-dichloro-n-[4-(4-chlorothiophen-2-yl) -5-(4-cyclohexylpiperazin-1-yl) thiazol-2-yl] nicotinamide | 570403-04-2 | |
5,6-Dichloro-N-(4-(4-chlorothiophen-2-yl) -5-(4-cyclohexylpiperazin-1-yl) thiazol-2-yl) nicotinamide | 570403-14-4 | |
Avatrombopag Base | 570406-98-3 | |
Ethyl 2-cyanoacetoacetate | 65193-87-5 | 1050477-31-0 Finerenone Intermedia |
4-Cyano-2-methoxybenzaldehyde | 21962-45-8 | |
4-Amino-2-hydroxy-5-methylpyridine | 95306-64-2 | |
(Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | 1050477-39-8 | |
Methyl 4-amino-2-methoxybenzoate | 27492-84-8 | 857890-39-2 Lenvatinib mesylate media |
4-chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 | |
4-Amino-3-chlorophenolum hydrochloridum | 52671-64-4 | |
4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide | 417716-92-8 | |
4-Amino-3-chlorophenol | 17609-80-2 | |
Phenyl hydrogenii [(R) -1-(6-amino-9H-purin-9-yl)propan-2-yloxy] methylphosphonatum | 379270-35-6 | Tenofovir Alafenamide Fumarate medius |
Tenofovir Alafenamide | 379270-37-8 | |
4-(3-fluoro-benzyloxy)-benzaldehyde | 66742-57-2 | Safinamide Mesylate media |
Safinamide | 133865-89-1 | |
(S) -1-(2,6-Dichloro-3-fluorophenyl) ethanol | 877397-65-4 | Crizotinib medium |
(R) -5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridinum-2-amine | 877399-00-3 | |
Tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-pyrazol-1-yl] piperidine-1-carboxylata | 877399-74-1 | |
4-Hydroxy-7-phenoxy-3-isoquinolinecarboxylic acidum methyl ester | 1455091-10-7 | Roxadustat Intermedia |
Ortho benzoyl acidum benzoicum | 85-52-9 | |
2-Aminobenzophenone | 2835-77-0 | |
2-Amino-5-bromodibenzophenone | 39859-36-4 | |
Orthobenzylaniline | 28059-64-5 | |
2-Amino-5-chlorodibenzophenone | 719-59-5 | |
2-Amino-4 '- fluorobenzophenone | 3800-6-4 | |
2-Amino-4 ' - Chlorobenzophenone | 2894-51-1 | |
1-Amino-2-benzoylnaphthalene | 153684-50-5 | |
2-Amino-5-bromo-2 '- fluorobenzophenone | 1479-58-9 | |
3-Methyl-4-methoxycarbonyl benzaldehyde oxime | 1261169-50-9 | Fluralaner Medium |
3 ', 5' - Dichloro-2,2,2-trifluorophenone | 130336-16-2 | |
2-Amino-N - (2,2,2-trifluoroethyl) hydrochloridi acetamidei | 1171331-39-7 | |
2-Methyl-4-acidi acetylbenzoicum | 55860-35-0 | |
Acidum cyanophenylboronicum 1,3-propanediolum cyclicum ester | 172732-52-4 | Perampanel medium |
2-benzonitrile acidum boricum pinacol ester | 214360-48-2 | |
5- (2-pyridyl) -1,2-dihydropyridin-2-one | 381233-78-9 | |
1 ' - phenyl - [2,3' - bipyridine] -6' (1'H) - one | 381725-50-4 | |
Acidum phenylboronicum | 98-80-6 | |
4- (4-aminophenyl) -3-methyl-4-acidi oxobutyrici | 42075-29-6 | Levosimendan Medium |
4- (4-aminophenyl) -3-methyl-4-oxobutyratum hydrochloridum | 120757-13-3 | |
4-Hydroxypyrrolo [2,3-d] pyrimidine | 3680-71-5 | Tofacitinib et Ruxolitinib medium |
4-Chloropyrrolidine | 3680-69-1 | |
(3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine dihydrochloride | 1062580-52-2 | |
4-methyl-7H-pyrrolino [2,3-d] pyrimidine | 945950-37-8 | |
2,4-Dihydroxypyridine | 626-03-9 | Pyridine media |
2,4-Dichloro-3-nitropyridine | 5975-12-2 | |
2,4-Dichloropyridine | 26452-80-2 | |
3-Amino-2,4-dichloropyridine | 173772-63-9 | |
2-Amino-5-methoxypyridine | 10167-97-2 | |
4-Amino-2-chloro-3-nitropyridine | 2789-25-5 | |
3-Chloro-4-cyanopyridine | 68325-15-5 | |
4-Chloro-3-nitropyridine | 13091-23-1 | |
2,6-Acidi Difluorophenylboronic | 162101-25-9 | |
2,6-Difluorophenol | 28177-48-2 | |
6-Chloro-1,3-dimethyluracil | 6972-27-6 | |
3-Nitro-4-chloroaniline | 635-22-3 | |
5-ethoxy-2-mercaptobenzimidazole | 55489-15-1 | |
Methyl nitroacetate | 2483-57-0 | |
2-Bromo-3-methylbenzonitrile | 263159-64-4 | |
1-Ethylpyrazole | 2817-71-2 | |
6-Bromo indoles 2-acidi carboxylici | 16732-65-3 | |
Methyl 2-amino-5-hydroxybenzoate | 1882-72-0 | |
2-Bromo acidum stericum | 142-94-9 | |
Chloromethyl acidum chlorosulfonicum ester | 49715-04-0 | |
1-tert butoxycarbonyl-3-hydroxy-pyrazolum 4-acidi carboxylicum ethyl niensis | 178424-17-4 | |
4-Bromo-1-methylpyrazole | 15803-02-8 | |
1-Acetoxy-2,3,5-tribenzoyloxy-1-beta-D-furan ribosum | 6974-32-9 | |
3-Nitro-4-chlorobenzenesulfonamide | 1997--9--6 | |
1,3-dimethyl-6-aminouracil | 6642-31-5 | |
(4-Cyclopropyl-6-methoxypyrimidin-5-yl) acidum boricum | 1798304-51-4 | |
3-Cyclopropyl-3-oxopropionatum yl ester | 32249-35-7 | Pitavastatin Calcium Intermediate |
2-Cyclopropyl-4- (4-fluorophenyl) -3-quinolinolum (pivalol) | 121660-11-5 | |
[2-Cyclopropyl-4- (4-fluorophenyl) -3-quinolinyl] methyl] triphenylphosphine bromide | 154057-58-6 | |
(4R cis) -6-aldehyde-2,2-dimethyl-1,3-dioxane-4-acetate tert butyl ester (D7) | 124752-23-4 | |
Pivastatin isopropyl tert butyl ester | 147489-06-3 | |
4- (6-aminopyridine-3-yl) piperazin-1-carboxylicum acidum tert-butyl ester | 571188-59-5 | Pabucilib medium |
6-Bromo-2-chloro-8-cyclopentylo-5-methyl-pyridino [2,3-D] pyrimidine. | 1016636-76-2 | |
4- (1,2-benzisothiazol-3-yl) -1-piperazine | 87691-87-0 | Iurasidone HCL Intermediate |
4- (1,2-benzisothiazol-3-yl) hydrochloride -1-piperazinum | 144010-02-6 | |
3AR, 4S, 7R, 7AS) 4,7-methylene-1H-isoindole-1,3 (2H) - dione | 14805-29-9 | |
(1R, 2R) -1,2-cyclohexanedimethanol | 65376-05-8 | |
1-(2-Chloroethyl) hydrochloridum azepane | 26487-67-2 | Bazedoxifene medium |
N-(2-Hydroxyethyl) | 20603-00-3 | |
2-Methyl-2-oxazoline | 1120-64-5 | Nefazodone intermedia |
1-Phenyl-1,2,3,4-tetrahydro-isoquinoline | 22990-19-8 | Solifenacin Medium |
6-Bromohexan-2-one | 10226-29-6 | Pentoxifylline Intermedia |
Mannose triflate | 92051-23-5 | Praecursor radiotracri 18FDG pro metabolismi cellulae imaginationis |
1-(4-Chlorophenyl) -1-phenylethanol | 59767-24-7 | Clemastine medium |
2-(2-Chloroethyl)-N-myry-pyrrolidine hydrochloridis | 56824-22-7 | |
1-Methyl-2-pyrrolidineethanol | 67004-64-2 | Clemastine abd Udenafil Intermediate |
2-(2-Aminoethyl) -1-methylpy | 51387-90-7 | Chloramidine media et aliis |
Dominus Hydroxyproline | 51-35-4 | |
Echinocandin B | 79411-15-7 | |
PneumocandinBo | 135575-42-7 | |
D-Glucosamine Hydrochloride | 66-84-2 | |
PYRROLOQUINOLINE QUINONE DISODIUM SAL' | 122628-50-6 | |
FR901379 | 144371-88-0 | micafungin medium |
FR179642 | 168110-44-9 | |
Ansamitocin P-3 | 66547-09-9 | |
Calicheamicin | 113440-58-7 | |
Dactinomycin | 50-76-0 | |
SAM (S-Adenosy-L-Methionine) | 200393-05-1 | |
Acidum Levulinic | 123-76-2 | |
Ethyl levulinate | 539-88-8 | |
butyl 4-oxopentanoate | 2052-15-5 | |
Tributyl PHOSPHATE | 126-73-8 | |
Triisobutyl phosphate | 126-71-6 | |
trioctyl phosphate | 78-42-2 |